GenCure

GenCure enables progress in the field of advanced therapies (also known as cell & gene therapies) by offering process and analytical development, bioproduction, in-process and release testing, while leveraging a unified quality management system. We partner with our users with the end goal of clinical development in mind, supporting the development of therapies often originating from academic institutions. GenCure's clinical-scale facility opened in March 2020, The bioproduction space is compliant with FDA regulations, EU Annex 1 and PMDA (Grade A, B, C, D). Cleanrooms are sized for a wide range of production volumes and multi-product capabilities, which can meet the need of a variety of research programs. This facility includes 6,700 square feet of cleanroom production space, a 2,500-square-foot development lab, along with office and meeting space. (Continued on Schedule O)